Redox Control of Wound Healing
伤口愈合的氧化还原控制
基本信息
- 批准号:6818478
- 负责人:
- 金额:$ 27.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-07-01 至 2008-06-30
- 项目状态:已结题
- 来源:
- 关键词:NAD(P)H dehydrogenaseangiogenesisantisense nucleic acidbiological signal transductionconfocal scanning microscopyelectrochemistryelectron spin resonance spectroscopyenzyme activityfocal adhesion kinasegene environment interactiongene expressiongenetically modified animalsgrowth factor receptorsimmunocytochemistryimmunoprecipitationlaboratory mousemicroarray technologyoxidation reduction reactiontissue /cell culturetransfectionvascular endothelial growth factorsvascular endotheliumwound healing
项目摘要
DESCRIPTION (provided by applicant):
Compromised wound tissue oxygenation has been long recognized as a key limiting factor in healing. Oxygen homeostasis has therefore been the center of major attention in wound healing research. Current findings indicate that a significant fraction of oxygen at the wound site is utilized to generate reactive oxygen species (ROS). ROS are classically described as accidental metabolic by-products, and are generally thought to be deleterious. The phagocyte NADPH oxidase deliberately generates ROS in transient bursts to kill pathogens. High concentrations of H2O2 (equal to or more than 1%) are used clinically for wound disinfection. However, there is a general agreement that at these doses H2O2 is harsh to regenerating cells and may not benefit overall healing. The recent discovery of another family of NADPH oxidases, the Nox/Duox family, provides additional examples of deliberate generation of ROS by non-phagocytic cells at the wound site. Upon induction, these cells generate low-levels of ROS on a sustained basis. Recent data support that such low concentration of ROS can regulate specific key redox-sensitive signaling processes most of which can be directly linked to wound healing. This proposal rests on our striking observation that genetic as well as pharmacological approaches to deliver low concentrations of ROS promote dermal wound angiogenesis, contraction and closure. Such low concentrations of ROS did not influence wound infection status. Strategies to decompose ROS at the wound site impaired healing. Taken together, these observations led to the hypothesis that resisting infection is not the sole role of ROS at the wound-site, and that ROS drives redox-signaling to support healing. Indeed, congenital defect in human NADPH oxidase results in impaired wound healing and antibiotics alone cannot correct such defect. We have observed that NADPH oxidase deficient transgenic mice suffer from impaired dermal healing even under infection-free conditions; the impairment is corrected by low-dose ROS delivery. Our working hypothesis is that ROS generated by wound-related cells (low-ROS by Nox; and residual ROS in the aftermath of phagocyte respiratory burst) support earlyphase acute wound healing by inducing redox-sensitive signal transduction pathways. Our long-term objective is to understand this new aspect of wound tissue oxygen homeostasis. We seek to illuminate the significance of redoxsensitive processes in wound healing, and to design redox-based strategies to promote healing. To test the stated hypothesis we propose the following three specific aims using standard models of murine acute dermal wound and in vitro culture of dermal microvascular endothelial cells: Aim 1. Investigate the role of ROS in excisional dermal wound vascularization, contraction and repair; Aim 2. Determine the significance of NADPH oxidases at the wound site; and Aim 3. Characterize the redox-sensitive mechanisms that regulate wound angiogenesis.
描述(由申请人提供):
伤口组织氧合作用受损一直被认为是愈合的关键限制因素。因此,氧稳态一直是伤口愈合研究的主要关注中心。目前的研究结果表明,伤口部位的大部分氧气被用来产生活性氧(ROS)。 ROS 通常被描述为偶然的代谢副产物,通常被认为是有害的。吞噬细胞 NADPH 氧化酶故意在瞬时爆发中产生 ROS 以杀死病原体。临床上多采用高浓度H2O2(等于或大于1%)进行伤口消毒。然而,人们普遍认为,在这些剂量下,H2O2 对再生细胞不利,可能无助于整体愈合。最近发现的另一个 NADPH 氧化酶家族(Nox/Duox 家族)提供了伤口部位非吞噬细胞有意产生 ROS 的更多例子。诱导后,这些细胞持续产生低水平的 ROS。最近的数据表明,如此低浓度的活性氧可以调节特定的关键氧化还原敏感信号传导过程,其中大部分可以直接与伤口愈合相关。该提议基于我们惊人的观察结果,即传递低浓度 ROS 的遗传和药理学方法可促进真皮伤口血管生成、收缩和闭合。如此低浓度的 ROS 并不影响伤口感染状态。在伤口部位分解 ROS 的策略会损害愈合。综上所述,这些观察结果得出这样的假设:抵抗感染并不是 ROS 在伤口部位的唯一作用,并且 ROS 驱动氧化还原信号以支持愈合。事实上,人类 NADPH 氧化酶的先天性缺陷会导致伤口愈合受损,仅靠抗生素无法纠正这种缺陷。我们观察到,NADPH 氧化酶缺陷的转基因小鼠即使在无感染的条件下也会出现真皮愈合受损的情况;这种损伤可以通过低剂量 ROS 输送来纠正。我们的工作假设是,伤口相关细胞产生的 ROS(Nox 产生的低 ROS;以及吞噬细胞呼吸爆发后残留的 ROS)通过诱导氧化还原敏感的信号转导途径支持早期急性伤口愈合。我们的长期目标是了解伤口组织氧稳态的这一新方面。我们试图阐明氧化还原敏感过程在伤口愈合中的重要性,并设计基于氧化还原的策略来促进愈合。为了检验上述假设,我们使用小鼠急性真皮伤口标准模型和真皮微血管内皮细胞体外培养提出以下三个具体目标: 目的 1. 研究 ROS 在切除真皮伤口血管化、收缩和修复中的作用;目标 2. 确定 NADPH 氧化酶在伤口部位的重要性;目标 3. 表征调节伤口血管生成的氧化还原敏感机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chandan K Sen其他文献
Chandan K Sen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chandan K Sen', 18)}}的其他基金
Cell Specific Gene Editing to Close Diabetic Wounds
细胞特异性基因编辑闭合糖尿病伤口
- 批准号:
10628884 - 财政年份:2023
- 资助金额:
$ 27.66万 - 项目类别:
Vitamin E Neuroprotection: Novel Molecular Mechanisms
维生素 E 神经保护:新颖的分子机制
- 批准号:
7382693 - 财政年份:2008
- 资助金额:
$ 27.66万 - 项目类别:
Vitamin E Neuroprotection: Novel Molecular Mechanisms
维生素 E 神经保护:新颖的分子机制
- 批准号:
7547006 - 财政年份:2008
- 资助金额:
$ 27.66万 - 项目类别:
Vitamin E Neuroprotection: Novel Molecular Mechanisms
维生素 E 神经保护:新颖的分子机制
- 批准号:
7994839 - 财政年份:2008
- 资助金额:
$ 27.66万 - 项目类别:
Vitamin E Neuroprotection: Novel Molecular Mechanisms
维生素 E 神经保护:新颖的分子机制
- 批准号:
7752535 - 财政年份:2008
- 资助金额:
$ 27.66万 - 项目类别:
相似国自然基金
基于Elabela-APJ轴探讨健脾化癥饮通过逆转EMT进而抑制胃癌血管生成拟态形成的机制研究
- 批准号:82305102
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Nrf1/2调控ACER2介导的SphK-S1P-S1PR通路在肝癌血管生成中的机制研究
- 批准号:82302988
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SFN-RAB7互作通过溶酶体自噬减少外泌体传递LncRNA H19调控肿瘤血管生成和鼻咽癌恶性进展
- 批准号:82360528
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
术藤合剂通过USP8介导的HIF-1α去泛素化调控血管生成拟态抑制结直肠癌侵袭转移的机制研究
- 批准号:82305330
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
兼具抑制内源性耗氧及抗血管生成水凝胶体系的优化及其逆转口腔鳞癌光动力乏氧抵抗的效果及机制研究
- 批准号:82373394
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
A new mouse model for testing splice-switching therapies in IGF-driven cancers
用于测试 IGF 驱动癌症中剪接转换疗法的新小鼠模型
- 批准号:
10373088 - 财政年份:2021
- 资助金额:
$ 27.66万 - 项目类别:
A new mouse model for testing splice-switching therapies in IGF-driven cancers
用于测试 IGF 驱动癌症中剪接转换疗法的新小鼠模型
- 批准号:
10202220 - 财政年份:2021
- 资助金额:
$ 27.66万 - 项目类别:
Elucidating the tumor suppressive effects of the sirtuin, SIRT1, in triple-negative breast cancer
阐明沉默调节蛋白 SIRT1 在三阴性乳腺癌中的肿瘤抑制作用
- 批准号:
10155077 - 财政年份:2020
- 资助金额:
$ 27.66万 - 项目类别:
Elucidating the tumor suppressive effects of the sirtuin, SIRT1, in triple-negative breast cancer
阐明沉默调节蛋白 SIRT1 在三阴性乳腺癌中的肿瘤抑制作用
- 批准号:
10676155 - 财政年份:2020
- 资助金额:
$ 27.66万 - 项目类别:
Elucidating the tumor suppressive effects of the sirtuin, SIRT1, in triple-negative breast cancer
阐明沉默调节蛋白 SIRT1 在三阴性乳腺癌中的肿瘤抑制作用
- 批准号:
10453657 - 财政年份:2020
- 资助金额:
$ 27.66万 - 项目类别: